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ABSTRACT      Asbestos fibers cause malignant tumors such as lung cancer and malignant 
mesothelioma. Furthermore, with carcinogenic activity, they alter the human immune system. 
Our previous findings indicated that immune cells exposed to asbestos revealed cellular and 
molecular alterations that resulted in a reduction in anti-tumor immunity. Focusing on regulatory 
T cells (Tregs), we found enhanced function and proliferating activity resulting from asbestos 
exposure using an in vitro  cell line model. Additionally, surface C-X-C motif chemokine receptor 
3 (CXCR3) levels in T helper (Th) cells as well as the capacity to produce interferon γ were 
reduced, which lead to decreased anti-tumor immunity. However, our recent findings showed 
that IL-17 production in the intracellular CXCR3-rich fraction in Th cells was enhanced by 
asbestos exposure. Regarding alterations of autoimmunity, some investigators have reported 
the detection of autoantibodies against endothelial cells and mesothelial cells in an asbestos-
exposed mouse model and suggested that these autoantibodies contribute to the formation of 
pulmonary fibrosis. However, the precise mechanisms by which asbestos affects the human 
immune system and causes cancers and the production of certain autoantibodies to create 
pathophysiological conditions found in asbestos-exposed patients remains to be elucidated.
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INTRODUCTION
   Asbestos fibers are mineral silicates that include Si 
and O１，２）. In addition to these elements, iron (Fe), 
magnesium (Mg) and sodium (Na) also comprise 
various asbestos fibers such as chrysotile, possessing 
the serpentine group Mg3(Si2O5)(OH)4, and amosite 
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and crocidolite which possess the amphibole groups 
Fe7Si8O22(OH)2 and Na2Fe
2+
3Fe
3+
2Si8O22(OH)2, 
respectively１，２）.
   Silicosis patients exposed to silica particles often 
reveal complications of autoimmune diseases３－６） 
 such as rheumatoid arthritis, known as Caplan's 
syndrome７）, systemic sclerosis８）, as well as anti-
neutrophil cytoplasmic autoantibody (ANCA)-
related vasculitis９，10）. Although the actions of silica 
particles to induce disruption of autoimmunity have 
been considered as adjuvant effects which generate 
small auto-antigens recognized by the immune 
system11，12）, our previous investigations showed 
that silica particles induce chronic activation of 
T helper (Th) responder (Tresp) cells as well as 
regulatory T (Treg) cells. As a result, Tresps begin 
to display certain activation markers such as soluble 
interleukin-2 receptor (sIL-2R)13－15）, program 
death-1 (PD-1)16） and CD6917）. Additionally, Tresps 
displayed certain surviving molecules such as 
soluble Fas/CD95 (sFas)18，19） and decoy receptor 3 
(DcR3)20） to prevent an attack of cell death ligands 
such as fas ligand and tumor necrosis factor-related 
apoptosis-inducing ligand (TRAIL). Thus, the 
imbalance between Tresps and Tregs manifests as 
higher Tresps and lower Tregs14，15）. This tendency 
forms the basis of the disruption of autoimmunity 
and people who possess this Tresp/Treg tendency 
may be prone to  the onset  of  autoimmune 
diseases14，15）.
   As asbestos fibers are mineral silicates, they may 
affect human immune cells. From our previous 
investigations, natural killer (NK) cells possess 
reduced cytotoxic activity following asbestos 
exposure due to a reduction in surface expression 
of one of the activation receptors, NKp4621，22）. 
Additionally, clonal expansion of CD8+ cytotoxic T 
lymphocytes (CTLs) was inhibited by the addition 
of chrysotile asbestos when assayed by the mixed 
lymphocyte reaction (MLR)23－25）.
   In this review, findings regarding anti-tumor 
immunity in Th cells and Tregs exposed to 
asbestos fibers are introduced. Additionally, our 
recent findings regarding IL-17 production in the 
intracellular C-X-C motif chemokine receptor 3 
(iCXCR3)-rich fraction following asbestos exposure 
have also been reported26）. Thereafter, the tendency 
toward anti-tumor immunity and disruption of 
autoimmunity caused by asbestos exposure is 
discussed.
EFFECTS OF ASBESTOS ON TH (CD4+) 
CELLS WITH A FOCUS ON CXCR3
   To investigate the effects of asbestos on human 
T cells, the human T cell leukemia virus (HTLV)-
1 immortalized human polyclonal T cell line MT-2 
was employed to establish continuous (more than 
eight months) and relatively low-dose (causes less 
than half of the cells to proceed to apoptosis when 
transiently exposed) exposure models27－32）. After 
continuous and low-dose exposure, MT-2 sublines 
showed cellular and molecular changes related to 
the acquisition of resistance to asbestos-induced 
apoptosis. 
   Among the various changes between original 
MT-2 cells not exposed to asbestos and MT-2 
sublines independently established by continuous 
and low-dose exposure to asbestos fibers such as 
chrysotile and crocidolite, surface expression of 
CXCR3 (sCXCR3) was examined since CXCR3 
plays an important role in anti-tumor immunity by 
marshaling interferon (IFN)-γ producing T cells 
to the area surrounding tumor cells. Using an MT-2 
cell line model in addition to ex vivo CD4+ T cells 
freshly isolated from healthy volunteers never 
exposed to asbestos, it was found that exposure to 
asbestos fibers resulted in reduced expression of 
surface CXCR3. Additionally, the cell line model 
and ex vivo cultivation model revealed a decrease 
in intracellular IFN-γ expression. These findings 
were confirmed using freshly isolated CD4+ T 
cells derived from patients exposed to asbestos and 
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diagnosed with pleural plaque (PP) or malignant 
mesothelioma (MM)28，29）. 
   MT-2  cells possess Treg-like function as 
previously reported33，34）, and given the initial 
observations regarding changes in CXCR3 
expression using MT-2 cells, the result might be 
considered to reflect a decrease in surface CXCR3 
in Treg following asbestos exposure. However, 
CXCR3 is widely expressed in human immune cells 
such as CD4+ Th, CD8+ T and NK cells. Thus, as 
mentioned above, an ex vivo exposure model was 
employed using freshly isolated peripheral CD4+ T 
cells from healthy volunteers. An ex vivo continuous 
exposure model (with exposure lasting four weeks 
with chronic stimulation with IL-2 in the absence or 
presence of asbestos fibers) was utilized as the next 
step from cell line model to confirm that freshly 
isolated cells might be useful for further analyses 
using these T cells from exposed patients.  Since 
Tregs represented a small percentage of peripheral 
CD4+ cells, most of this population comprised 
Th cells. Following confirmation of the decrease 
in CXCR3 expression in CD4+ Th cells by the ex 
vivo model cultured with asbestos fibers, the assay 
was then utilized to examine CXCR3 expression 
in asbestos-exposed patients with as PP and MM. 
Surface expression of CXCR3 in peripheral CD4+ 
cells were compared among healthy volunteers, and 
patients with PP and MM. A reduction of CXCR3 
in peripheral CD4+ Th cells in these patients was 
demonstrated. Although these experiments did 
not exactly differentiate any changes in CXCR3 
expression in Th or Treg cells, most of the analyzed 
cell population comprised Th cells. It was then 
considered that the reduction in CXCR3 expression 
leads to a decrease in anti-tumor immunity. 
   Thereaf ter,  we inves t iga ted  changes  in 
intracellular (iCXCR3) expression in freshly 
isolated CD4+ T cells from healthy volunteers using 
an ex vivo model. After dividing CD4+ T cells by 
sCXCR3, no marked differences were found in the 
expression of intracellular IFN-γ, IL-17 or CXCR3 
when sCXCR3+ and sCXCR3- subpopulations 
were compared. In this model, peripheral CD4+ 
cells were stimulated with IL-2 following initial 
activation using anti-CD3 and anti-CD28 antibodies 
in the absence or presence of various amounts 
of chrysotile asbestos fibers.  Additionally, 
after removing the asbestos fibers,  cells were 
restimulated with mitogens (phorbol 12-myristate 
13-acetate (PMA) and ionomycin). During this 
second stimulation, IL-17  production in the 
culture medium showed a dose-dependent increase 
depending on the initial supplemented chrysotile 
concentration (even though there was no statistical 
significance due to larger error bar values), although 
IFN-γ production showed no marked changes 
following the addition of chrysotile fibers28）. 
Thereafter, we examined mRNA expression of T-bet 
(T-box transcription factor for differentiation to 
Th1), IFN-γ, retinoic acid-related orphan receptor 
γt (RORγt; transcription factor for skewing to 
Th17) and IL-17 in CD4+sCXCR3+ T cells and 
CD4+sCXCR3- T cells cultured in the absence or 
presence of chrysotile fibers following stimulation 
with mitogens. As a result, no significant changes 
were found in mRNA levels of T-bet, IFN-γ or 
RORγt, while mRNA expression of IL-17 increased 
significantly in the CD4+sCXCR3+ fraction in 
a dose-dependent manner of the supplemented 
chrysotile fibers28）. Unfortunately, expression of 
CCR6, the other special marker for Th17 cells, 
was not examined in this study. Moreover, the 
discrepancy between increased IL-17 production as 
well as mRNA expression and unchanged RORγt 
expression was hitherto unresolved. 
E F F E C T S  O F  A S B E S T O S  O N  T R E G 
FUNCTION AND PROLIFERATION
   Since MT-2 cells possess Treg-like function33，34）, 
Treg cellular function and proliferation were 
examined and compared between MT-2 original 
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cells and sublines continuously exposed to 
asbestos. As previously reported, we found that 
function was enhanced by cell-cell contact as 
well as over-production of soluble factors such 
as IL-10 and transforming growth factor (TGF)-
β35）. Additionally, sublines showed acceleration 
of cell cycle progression by increased expression 
of accelerating molecules such as cyclin D1 and 
decreased expression of braking molecules such 
as cyclin-dependent kinase inhibitors (CDK-Is) 
including p21Cip1, p27Kip1 and p16CDKN2A 36）. These 
changes were regulated by forkhead box protein 
O1 (FoxO1) transcription factor37）. Expression 
of FoxO1 in MT-2 sublines exposed to asbestos 
was markedly lower compared with that of MT-2 
original cells. 
   Taken together, asbestos causes an increase and 
enhancement of Tregs. This is consistent with our 
hypothesis in which asbestos causes a reduction in 
anti-tumor immunity.
A U T O A N T I B O D Y P R O D U C T I O N  B Y 
ASBESTOS EXPOSURE
   As we previously reported38－42）, silicosis patients 
showed the appearance of various autoantibodies 
(AAb) such as anti-Scl-70 (topoisomerase I) ‐
AAb38）,  anti-centromere (CENP-B) ‐AAb39）, 
anti- desmoglein-AAb40）, anti-Fas-AAb41） and 
anti-caspase-8-AAb42）.  Other investigations 
have  demons t r a t ed  AAb p roduc t ion  wi th 
asbestos exposure such as anti-endothelial 
cell AAb, anti-fibroblast antibody, and anti-
mesothelial antibody43－45）. Although some AAbs 
were found in a mouse model, some AAbs were 
found in humans comprising a “Libby Amphibole 
(LA)”-exposed population. LA comprises a mixture 
of amphibole fibers that contain contaminated 
vermiculite, and is mined at Libby, Montana, 
U.S.A43－45）. The researchers considered that these 
antibodies may play a role in the formation of lung 
and pleural fibrosis caused by asbestos exposure. 
INTERACTION BETWEEN TH17 AND TREG 
CELLS
   As shown above, we found an enhancement of 
function and proliferation of Tregs by asbestos 
exposure. Unfortunately, it was impossible to 
measure peripheral and/or tumor surrounding Tregs 
in asbestos-exposed population. However, our 
findings support the notion that a reduction in anti-
tumor immunity is induced by these Treg changes 
caused by asbestos exposure, in addition to a 
reduction in sCXCR3 and IFN-γ in CD4+ Th cells, 
decreased differentiation of CTLs23－25）, as well as 
impaired function of NK cells21，22）.
   On the other hand, the iCXCR3 population in 
CD4+ Th cells showed an increased capacity to 
produce IL-17. Since IL-17 is mainly produced by 
Th17 cells, asbestos exposure can skew some of the 
Th cells toward Th17 cells. Essentially, Th17 cells 
are considered to possess an important role in the 
disruption of autoimmunity, and that the increase 
in Th17 may facilitate the onset of autoimmune 
diseases. 
   Additionally, the skewing toward Th17 or 
Treg cells is thought to be induced by cytokine 
conditions surrounding Th naïve cells. Although 
only TGF-β can facilitate the differentiation of 
naïve T cells into Treg cells, TGF-β with IL-6 can 
induce differentiation of Th naïve cells into Th17 
cells46－49）. As we previously reported, T cells from 
patients with PP or MM showed increased capacity 
to produce IL-6. Additionally, in patients with 
MM, serum IL-6 levels were higher compared with 
healthy volunteers and patients with PP 50）. 
CONCLUSION
   Fig. 1 schematically shows findings described in 
this review. 
   These complex findings suggest that (1) asbestos 
exposure induces enhancement of Tregs, (2) asbestos 
exposure causes differentiation of a small population 
of Th cells (sCXCR3+ cells) toward Th17 cells 
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Fig. 1. The effects of asbestos fibers on Th, Treg and Th17 cells are schematically summarized in this figure from the viewpoint 
of decreased anti-tumor immunity and disruption of autoimmunity. Asbestos is a mineral silicate containing iron, magnesium and 
so on. Although the physical properties of fibrous substances differ from that of silica particles, asbestos may affect immune cells, 
as silica caused a disruption in autoimmunity. Regarding CXCR3 in CD4+ helper T cells, asbestos exposure resulted in a decline 
in surface (s) CXCR3 expression. Examination of CD4 T cells exposed to asbestos revealed a gradual decrease in sCXCR3 as 
well as intracellular (i) CXCR3. Additionally, the capacity to produce IFNγ was also reduced. However, recessive populations of 
CD4+ cells exposed to asbestos still maintained sCXCR3 expression, gradually began to produce IL-17, and were skewed toward 
Th17 cells. Th17 cells in the presence of asbestos possess the capacity to produce auto-antibodies against endothelial, fibroblast 
and mesothelial cells. These autoantibodies are reported to contribute towards the formation of pulmonary fibrosis. On the other 
hand, asbestos exposure may alter the cytokine environment surrounding T cells. Although further studies are required, the altered 
environment may modify the skewing conditions and outcomes, especially between Th17 and Treg cells. Asbestos exposure 
enhanced Treg function and led to increased volume. All of these effects of asbestos on human immune cells lead to a reduction 
in anti-tumor immunity and facilitate the onset of pulmonary fibrosis.
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when increased IL-6 is present, although sCXCR3+ 
T cell levels decreased with asbestos exposure, and 
(3) a small fraction of IL-17-producing Th cells 
may possess the capacity to produce AAbs found in 
asbestos-exposed populations and may contribute 
toward the onset of pulmonary fibrosis. However, 
since these possibilities have yet to be completely 
investigated, additional investigations will be 
required.
   Further studies are required to identify the kinds of 
alterations that occur to the immune system resulting 
from continuous exposure to asbestos, and which 
contribute to asbestos-induced pathophysiological 
conditions such as the occurrence of malignant 
tumors, formation of pulmonary fibrosis, as well 
as the appearance of autoimmune disorders. 
Additionally, with regard to the disruption of 
autoimmunity, the effects of silica and asbestos 
exposure on the immune system should be examined 
and any similarities and differences be noted. 
This would help to clarify immune modifications, 
and together with improved knowledge of certain 
substances in foods, plant extracts, and others 
sources, may assist in the development of strategies 
to facilitate recovery of the immune system, and 
help prevent future occurrences of silica- and 
asbestos-induced diseases.
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